Cargando…

Retrospective Cohort Study of the Effectiveness of the Sputnik V and EpiVacCorona Vaccines against the SARS-CoV-2 Delta Variant in Moscow (June–July 2021)

The goal of this study was to evaluate the epidemiological effectiveness of the Sputnik V and EpiVacCorona vaccines against COVID-19. This work is a retrospective cohort study of COVID-19 patients. The cohort created by the Moscow Health Department included more than 300,000 infected people who soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matveeva, Olga, Ershov, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320764/ https://www.ncbi.nlm.nih.gov/pubmed/35891148 http://dx.doi.org/10.3390/vaccines10070984

Ejemplares similares

Antimicrobial Activity of the Serum before and after Vaccination with EpiVacCorona
por: Arzumanyan, V. G., et al.
Publicado: (2022)

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)
por: Ryzhikov, Alexander B., et al.
Publicado: (2023)

Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case–control study
por: Barchuk, Anton, et al.
Publicado: (2022)

Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients
por: Laham, Gustavo, et al.
Publicado: (2022)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

The arrival of Sputnik V
por: Balakrishnan, Vijay Shankar
Publicado: (2020)

Assessment of the humoral immunity induced by Sputnik V Covid-19 vaccine (GAM-COVID-VAC) in healthcare workers()
por: Cordova, Ezequiel, et al.
Publicado: (2022)

Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
por: Sukhikh, Gennady T., et al.
Publicado: (2022)

Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis
por: Pereson, Matías J., et al.
Publicado: (2022)

Sputnik V vaccine goes global
por: Lawton, Graham
Publicado: (2021)

Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)

Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination
por: da Silva, Almir Ribeiro, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Delta Variant, Benin, May–July 2021
por: Yadouleton, Anges, et al.
Publicado: (2022)

WCN23-0034 A COMPARISON OF GAM-COVID-VAC (SPUTNIK V) VACCINE IMMUNOGENICITY IN HEMODIALYSIS PATIENTS AND NON-RENAL SUBJECTS
por: PARSHINA, E., et al.
Publicado: (2023)

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
por: Shah, Syed Ahmar, et al.
Publicado: (2021)

Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
por: Li, Jianhua, et al.
Publicado: (2022)

Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population
por: Fernandes-Matano, Larissa, et al.
Publicado: (2023)

ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance
por: Montalti, Marco, et al.
Publicado: (2021)

ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance
por: Di Valerio, Zeno, et al.
Publicado: (2022)

Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021
por: Blanquart, François, et al.
Publicado: (2021)

Outbreak of SARS-CoV-2 B.1.617.2 (Delta Variant) in a Youth Camp Associated With Community Spread, Nebraska, June–July 2021
por: Bai, Julia (He), et al.
Publicado: (2022)

Functional Characteristics of Serum Anti-SARS-CoV-2 Antibodies against Delta and Omicron Variants after Vaccination with Sputnik V
por: Radion, Elizaveta I., et al.
Publicado: (2023)

Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022)

CoronaVac and ChAdOx1 Vaccination and Gamma Infection Elicited Neutralizing Antibodies against the SARS-CoV-2 Delta Variant
por: Fumagalli, Marcilio Jorge, et al.
Publicado: (2022)

Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge
por: Dmitrieva, Ksenia, et al.
Publicado: (2023)

Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021
por: Alizon, Samuel, et al.
Publicado: (2021)

Complete Genome Sequence of the Oncolytic Sendai virus Strain Moscow
por: Zainutdinov, Sergei S., et al.
Publicado: (2016)

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma
por: Wang, Yingdan, et al.
Publicado: (2022)

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
por: Chen, Yuxin, et al.
Publicado: (2021)

An Integrative Analysis of the Immune Features of Inactivated SARS-CoV-2 Vaccine (CoronaVac)
por: Jiang, Zhujun, et al.
Publicado: (2022)

Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants
por: Au, Wing Ying, et al.
Publicado: (2022)

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

CoronaVac efficacy data from Turkey
por: McMenamin, Martina E, et al.
Publicado: (2021)

Long Term Immune Response Produced by the SputnikV Vaccine
por: Martynova, Ekaterina, et al.
Publicado: (2021)

Can children of the Sputnik V vaccine recipients become symptomatic?
por: Mehraeen, Esmaeil, et al.
Publicado: (2021)

Antibody durability at 1 year after Sputnik V vaccination
por: Sanchez, Lautaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vmkn8jppu647k0hd0ofoi9kro0